ENDRA Life Sciences (NDRA) Reports In-Line Q1 EPS

ENDRA Life Sciences (NASDAQ: NDRA) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• TPU-As-A-Service could boost Google’s 2028 profit by over 15%: Barclays
• HSBC starts SpaceX at Hold, sees execution risks tempering long-term AI ambitions